Abstract:Background: Cognitive deficits are believed to be the primary deficits in schizophrenia, persisting even after reduction or resolution of primary symptoms of hallucinations and delusions. Cognitive deficits reportedly occur in all studies of schizophrenia, but whether they progress in linear severity from subjects who are at high risk for schizophrenia to first episode and later to chronic schizophrenia needs further investigation. We present preliminary results from a study of cognitive deficits in normal controls, 3 categories of high-risk subjects, and patients with first-episode and chronic schizophrenia. Methods: We report cognitive deficit results from a larger study that focused on epigenetic biomarkers in the lymphocytes of patients with schizophrenia in China. We assessed cognitive function in normal controls, in 3 groups at high risk for schizophrenia (HR)—(1) subjects with a family member with schizophrenia (FAMHR), (2) subjects with prodromal symptoms of schizophrenia (PRODROMALHR), and (3) subjects with both prodromal symptoms and a family history (ULTRAHR)—and in first-episode schizophrenia (FSZ) and chronic schizophrenia (CSZ) patients. Cognitive functions were evaluated in all subjects using the MATRICS battery. All patients were evaluated by family history and the PANSS interview. HR subjects were also evaluated with the SIPS interview. Results: MATRICS battery scores for combined HR subjects generally suggest declines in cognitive performance and are intermediate between controls and subjects with schizophrenia. These declines in HR subjects were statistically significant (P < .05) compared to controls in the MATRICS components of Overall Composite Score, Speed of Processing, Visual Learning, and Reasoning-Problem Solving. FSZ and CSZ showed more severe deficits but were not significantly different from each other on any of the MATRICS domain scores. Within the subcategories of HR subjects, the FAMHR group did not significantly differ from controls on any cognitive measure, although they had slightly lower mean scores, but a statistically significant decline was seen in the PRODROMALHR group. However, FSZ and CSZ had significantly more severe cognitive deficit scores than the PRODROMALHR group. We are currently analyzing the relationship between cognitive decline and symptom scores on SIPS and PANSS. Conclusion: Significant cognitive deficits are observed in HR subjects before development of schizophrenia, but become prominent only in HR subjects who develop prodromal symptoms. These symptoms worsen until the onset of FSZ but do not to appear to worsen throughout progression of the illness in this sample.

Study on the cognitive dysfunction in patients with first-episode schizophrenia

Cognitive Disorder in Schizophrenia

The comparative study of cognitive functions between familial and sporadic patients with first-episode schizophrenia

The neurocognitive function in patients with first-episode schizophrenia treated in early stage

Study of Executive Function in Adolescent Patients with First-Episode Schizophrenia

Evaluation of Cognitive Functions and Its Corelation with Psychiatric Symptoms in Patients with Schizophrenia

Spatial working memory in patients with deficit and nondeficit schizophrenia

Cognitive function changes with risperidone monotherapy and their relationship to psychotic symptoms in treatment-na?ve first-episode schizophrenia patients

Relationship Between Iq and Memory and Executive Function in First Episode Schizophrenia

Cognitive Impairments in First-Episode Drug-Naive and Chronic Medicated Schizophrenia: MATRICS Consensus Cognitive Battery in a Chinese Han Population.

The Comparison of Impairment of Cognitive Function in First-Episode Schizophrenia, Bipolar Disorder and Major Depressive Disorder

The Characteristics of Cognitive Function in Patients with Schizophrenia

Cognitive function in patients with early onset and adult onset schizophrenia

Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study

Intellectual characteristics measured with the Chinese version of the Wechsler Adult Intelligence Scale-Fourth Edition in patients with schizophrenia

A study of cognitive function in patients with childhood schizophrenia

Factor structures of the neurocognitive assessments and familial analysis in first-episode schizophrenia patients, their relatives and controls.

Cognitive function in patients with first-episode schizophrenia and individuals at high-risk for psychosis

Intelligence and Related Factors in Schizophrenia

Cognitive Deficits in Subjects at Risk for Psychosis, First-Episode and Chronic Schizophrenia Patients.

SU40. Cognitive Function Deficits in High-Risk, First-Episode, and Chronic Schizophrenia